The current state of tobacco cessation treatment

19Citations
Citations of this article
57Readers
Mendeley users who have this article in their library.

Abstract

Nicotine addiction and dependence is a chronic relapsing disease driven by addiction to nicotine. Proactive treatment for all tobacco users, regardless of their readiness to quit, is recommended. First-line tobacco cessation medications include nicotine replacement therapy, bupropion, and varenicline. Comprehensive treatment with behavioral interventions and pharmacologic therapy increases success rates of smoking cessation. Although there are many popular alternative treatments, they should not replace or delay the use of known effective therapies.

Cite

CITATION STYLE

APA

Choi, H. K., Lin, C., Ataucuri-Vargas, J., & Singrey, A. (2021). The current state of tobacco cessation treatment. Cleveland Clinic Journal of Medicine, 88(7), 393–404. https://doi.org/10.3949/CCJM.88A.20099

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free